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ABSTRACT
Motivation: Meta-analysis of genomics data seeks to identify genes
associated with a biological phenotype across multiple datasets; how-
ever, merging data from different platforms by their features (genes) is
challenging. Meta-analysis using functionally or biologically character-
ized gene sets simplifies data integration is biologically intuitive and is
seen as having great potential, but is an emerging field with few es-
tablished statistical methods.
Results: We transform gene expression profiles into binary gene set
profiles by discretizing results of gene set enrichment analyses and
apply a new iterative bi-clustering algorithm (iBBiG) to identify groups
of gene sets that are coordinately associated with groups of pheno-
types across multiple studies. iBBiG is optimized for meta-analysis of
large numbers of diverse genomics data that may have unmatched
samples. It does not require prior knowledge of the number or size of
clusters. When applied to simulated data, it outperforms commonly
used clustering methods, discovers overlapping clusters of diverse
sizes and is robust in the presence of noise. We apply it to
meta-analysis of breast cancer studies, where iBBiG extracted novel
gene set—phenotype association that predicted tumor metastases
within tumor subtypes.
Availability: Implemented in the Bioconductor package iBBiG
Contact: aedin@jimmy.harvard.edu
Received on November 21, 2011; revised on May 11, 2012; accepted
on July 5, 2012
1I N T R O D U C T I O N
Genomic studies have generated vast quantities of data, includ-
ing gene expression, copy number variation and single-nucleotide
polymorphisms. Tens of thousands of gene expression profiling
experiments are stored in public repositories (Barrett et al., 2009;
Parkinson et al., 2009) and are increasingly studied in aggregate.
The aim of these studies is typically to discover a set of genes that
participate in a pathway and are robustly predictive of a biolo-
gical phenotype in a meta-analysis of multiple studies.
Gene set analysis (GSA) was developed to identify such gene
sets whose expression distinguishes biological conditions, even if
single-gene analysis fails to find significant associations with the
phenotype. The method takes advantage of a priori defined gene
sets published in gene set databases (Gene Ontology, KEGG and
MSigDB) or resulting from differential expression studies
(MSigDB and GeneSigDB) (Culhane et al., 2009, 2012;
Subramanian et al., 2005). GSA has been successfully applied
to the analysis of microarray experiments (Goeman and
Buehlmann, 2007; Mootha et al., 2003) and has been extended
beyond transcriptomics to other areas, such as analysis of
genome-wide association studies (Cantor et al.,2 0 1 0 ;W u
et al., 2008). When compared to traditional single-gene analysis
that ranks differential gene expression between two conditions,
GSA produced more consistent biological results across studies
even when some genes in a gene set were absent or poorly rep-
resented in a dataset (Fan et al., 2011). Although GSA naturally
extends to integrated meta-analysis, surprisingly few studies have
applied meta-GSA to integration of multiple datasets (Segal
et al., 2004; Montaner and Dopazo, 2010). Most meta-GSA
approaches are designed for the limited case, where datasets
have matched samples or features (Montaner and Dopazo,
2010; Tyekucheva et al., 2011). These either create a merged
dataset of features (genes) common to all datasets and perform
a GSA or apply GSA on each individual datasets and then com-
bine the resulting GSA statistics or P-values to produce a ranked
list of gene sets (Montaner and Dopazo, 2010; Shen and Tseng,
2010; Tyekucheva et al., 2011).
While a single ranked list of gene sets may capture the biolo-
gical complexity of a simple cellular system, it is insufficient when
applied to the study of complex disease or meta-analysis of large
numbers of studies where different pathways are active in differ-
ent subsets of samples. These limitations can be addressed using
bi-clustering, a simultaneous similarity-based clustering of fea-
tures and conditions, resulting in modules; subsets of features
that exhibit consistent patterns over subsets of conditions
(Cheng and Church, 2000). Numerous bi-clustering approaches
have been applied to continuous (Cheng and Church, 2000;
Hochreiter et al., 2010; Huttenhower et al., 2009) and discretized
gene expression profiles (Prelic, 2005); however, these methods
have not been applied in meta-GSA.
We introduce iterative Binary Bi-clustering of Gene sets
(iBBiG), a new bi-clustering algorithm to perform meta-GSA
that addresses the shortcomings of ‘ranked list’ meta-GSA
approaches. It scales well when applied to hundreds of datasets
is tolerant to noise characteristic of genomics data and when
applied on simulated data, outperforms clustering and
bi-clustering methods including hierarchical and k-means cluster-
ing, FABIA (Hochreiter et al., 2010), COALESCE
(Huttenhower et al., 2009) and Bimax (Prelic, 2005). To perform
meta-GSA, we first transform ‘noisy’ gene expression profiles to *To whom correspondence should be addressed.
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study of different studies as it negates the need to match
probes across platforms. We then apply iBBiG to extract clusters
or ‘modules’ of groups of phenotypes whose gene expression
profiles are enriched in similar gene sets (Supplementary
Fig. 1). An attractive feature of iBBiG is that it does not require
prior knowledge or limit the number or size of clusters, a
non-trivial requirement in cluster analysis of most large biolo-
gical datasets. The results of iBBiG are easy to parse; iBBiG
modules are ranked by an information score, and within each
module, gene sets are ranked by a fitness score that measures its
weight in the module. It uses a genetic algorithm to maximize the
size and entropy of each bi-cluster producing a small number of
bi-clusters whose functional and phenotypic associations can be
easily interpreted; eight modules were associated with known
breast cancer clinical covariates in meta-GSA of 21 breast
cancer gene expression datasets, and we detected 13 modules
prognostic both within and across breast cancer molecular sub-
types using a cluster discovery approach, which ignored a priori
sample knowledge.
2 MATERIALS AND METHODS
We tested the ability of iBBiG to discover bi-clusters in matrices of real
and simulated data. Real gene expression data were transformed to gene
set profiles using two different GSA approaches (i) single sample and (ii)
pairwise test which were computed using the Bioconductor packages gene
set variation analysis (GSVA) and GSEAlm (Oron et al., 2008), respect-
ively. GSVA ranks gene sets within each individual gene expression pro-
file to produce a gene set by sample matrix. GSEAlm tests for enrichment
of gene sets in a ranked list of genes that are differential expressed be-
tween two conditions or clinical covariates (e.g. Grade 1 versus Grade 3)
resulting in a gene set by pairwise test matrix. Resulting GSA P-values are
discretized generating a spare binary matrix. Columns contain ‘pheno-
types’ defined by single sample or a pairwise test GSA results, in which 1
is a significant association (P50.05) between a gene set and phenotype
and 0 represents a lack of association.
2.1 Datasets
2.1.1 Single sample GSA data Normalized gene expression of pri-
mary breast tumors was download from GEO (GSE20685, n¼327) (Kao
et al., 2011) or imported from the Bioconductor data packages
breastCancerNKI (n¼337) (van’t Veer et al., 2002), and
breastCancerVDX (n¼344) (Minn et al., 2007). Data were obtained on
Affymetrix U133 Plus2, Agilent and Affymetrix U133a GeneChip arrays;
each contained different numbers of features. GSVA was applied using
gene sets from C2 subset of MSigDB v3.0 to transform gene expression
data into gene set x sample matrices. No prior knowledge or covariates
were used in GSVA. The resulting values were discretized (es.os  0.3) to
produce an association matrix of sparse (11.6%, n¼1) binary data of
1008 columns (breast cancer samples) and 5098 rows (up and
down-regulated results for 2459 gene sets). iBBiG was applied with de-
fault parameters with nModules¼20.
2.1.2 GSEAlm data To discover modules associated with known
breast cancer clinical covariates, 21 normalized breast cancer gene expres-
sion datasets (3875 gene expression profiles, see Supplementary Table S1)
annotated with 107 clinical covariates were obtained from the GeneChip
Ontology Database (Liu et al., 2011). Clinical covariates included tumor
grade, stage, age or hormone status. GSEAlm (Oron et al., 2008) was
applied to all pairwise combinations of each covariate. For example, if
the covariate grade has levels 1, 2 and 3, all possible pairwise combin-
ations would result in six phenotypes (Grades 1v2,1v3,2v1,2v3,3v1 and
3v2), therefore pairwise tests of the 107 covariates resulted in 448 pheno-
types. GSEAlm was performed independently and we did not merge
studies at the probe (gene), sample or phenotype level. Gene sets from
the C2 and C5 subsets of MSigDB v2.0 (n¼2293) (Subramanian et al.,
2005) and GeneSigDB v1.0 (n¼560) (Culhane et al., 2009) were used.
Resulting P-values were corrected for multiple testing using the false
discovery rate (Benjamini and Hochberg, 1995) and discretized
(P50.05), to produce an association matrix of sparse binary data with
448 columns (pairwise tests) and 2853 rows (gene sets). iBBiG was applied
to detected 50 modules. Examination of the fitness score and module size
plots (Supplementary Fig. 24) identified eight modules that had a fitness
score of over 1000 and a minimum of five pairwise tests.
2.1.3 Simulated data using observations of GSA results of real
data, we simulated a dataset of 400 pairwise tests by 400 gene sets in
which we placed seven modules (M1–M7; Fig. 1). These were introduced
by assigning associations (value of 1) to column and row pairs. To rep-
licate the expected properties of real data, modules were created such that
they partially overlap in columns, in rows and in both directions; M1 gene
sets overlapped with all modules except M3. M2 overlapped pairwise tests
with modules M4–7. Artificial modules had highly variable sizes and
included ‘wide’ modules driven by a large number of pairwise tests with
few gene sets and ‘tall’ modules like M1 which contained 25 pairwise tests
with a large number of gene sets (n¼250). This latter module (with many
gene sets) might represent a complex, well-characterized biological pro-
cess such as proliferation. Random background noise (at 10%), which is
characteristically observed in genomics data, was also added. In real data
the signal strength will vary both between and within modules. Therefore,
Fig. 1. Data were simulated to represent discretized P-values from GSA
of 400 pairwise tests and 400 gene sets. Associations are shown in gray,
whereas non-associations are in white. The dataset has 10% background
noise and contains seven overlapping clusters of gene set modules. These
include overlaps of pairwise tests (columns), overlaps of gene sets (rows)
and overlaps in both dimensions. There were different signal strength
gradients with each module M1 (90–40%), M2 (80–50%), M3
(80–40%), M4 (90–50%), M5 (80–40%), M6 (90–40%) and M7
(60–50%)
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Bi-clustering of binary datato simulate variance among modules, random noise (replacing values of 1
with 0) was imposed to produce modules with different signal strengths
(Fig. 1). Within a module, we expect to see few strong signals (gene sets
associated with all pairwise tests) and many weaker signals. Therefore,
within each module, a noise gradient was also applied so that the first
gene sets had a greater number of associations (Fig. 1). This within-noise
gradient ranged from 10 to 60% and varied between modules. The size,
signal strength and signal gradient of each module are provided in
Table 1. Overlaps are visualized in Figure 1. R code to generate this
data (using the function makeArtificial available in our Bioconductor
package iBBiG) is provided in Supplementary Materials. iBBiG was
also applied to the 21 real datasets in which the sample labels were
permuted by random shuffle, but only recovered small modules (2 and
3 pairwise tests) with low or negative weighted scores (data not shown).
2.2 Methods
The iBBiG algorithm identifies bi-clusters (or modules) in a matrix of
binary data and consists of three main components (i) a module fitness
score (ii) a heuristic search algorithm to identify and grow modules in a
high dimensional search space and (iii) an iterative extraction method to
mask the signal of modules that have already been discovered.
2.2.1 Fitness score The module fitness score measures both module
size and homogeneity. A module yields a high fitness score when a large
group of phenotypes are associated with the same features (gene sets). We
use the term phenotype to indicate a binary vector of discretized P-values
resulting from either a pairwise test (GSEAlm) or single sample (GSVA)
GSA. Module homogeneity is evaluated using Shannon’s Entropy
(Shannon, 1948), a standard approach to measure homogeneity, often
used in cluster analysis Jenssen et al. (2003) and Li et al. (2004). An
asymmetrical score was used; associations are considered and
non-associations that can result from multiple technical causes are
ignored. Assume a binary matrix M,w i t hm columns (phenotypes) and
n rows (features or gene sets), in which an element mij f1,0} represents an
association between phenotype j and gene set i. Given a module K with k
phenotypes, where 2 k m, the probability of an association between a







Subsequently, the entropy Hi of gene set i and phenotypes in K can be
calculated
Hi ¼  pi log2 pi  ð 1   piÞlog2ð1   piÞ; ð2Þ
where 0.log2 0¼0 (Shannon, 1948). Hi has the range 0 Hi 1, where
Hi¼0 when a gene set is associated (pi¼1) or not associated (pi¼0), with
all k phenotypes. Hi¼1 when associations are random pi¼0.5.
The score Si of gene set i in module K is weighted. The weight matrix
W has the same dimension as matrix M and equals M on the first iter-
ation (when finding the first module), but for subsequent iterations an
element wij of W is modified if mij was included in a module. The weight





Si ¼ Wikð1   HiÞ
 if pi > 0:5
0i f pi   0:5:
 
ð4Þ
The parameter   (range 05 51.0) is a weighting factor that balances
module homogeneity and module size (number of phenotypes versus
number of genesets). Clearly one could have a large module with low
homogeneity and vice versa. Consequently,   balances the tradeoff be-
tween specificity and sensitivity (Supplemental Fig. 3). The optimal de-
fault value (described below) was determined to be  ¼0.3
(Supplementary Table 2). Supplemental Figure 2 depicts the behavior
of the entropy-based score for a single gene set. A score for an entire
module S is calculated by summing up the n gene set scores Si, which can
be optimized with the addition or omission of phenotypes. A beneficial
side effect of this approach is the weighting of gene sets (Supplementary
Figs. 4 and 5). The weight indicates the importance of a gene set to a
Table 1. Module nomenclature (M1–M7) is the same as that used in Figure 1
M1 M2 M3 M4 M5 M6 M7
D i m e n s i o n 2 52 5 0 1 7 5 7 55 05 0 4 04 03 03 02 02 04 04 0
s i g n a l 0 . 40 . 90 . 40 . 80 . 50 . 8 0 . 40 . 90 . 40 . 80 . 60 . 90 . 50 . 6
Noise Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens Spec Sens
0.00 100 98.4 99.7 98.5 100 92.6 99.9 96.7 98.7 80.5 99.4 57.5 100 75.1
0.05 100 98.8 99.6 99.1 100 94.6 100 97.1 98.8 78.8 99.7 78.4 100 74.8
0.10 100 99.0 99.6 98.9 100 99.0 100 98.0 98.7 79.4 99.8 72.0 100 73.1
0.15 100 98.9 99.6 98.9 100 98.6 100 97.7 98.8 69.7 99.7 66.2 100 74.3
0.20 100 99.2 99.4 98.5 100 98.8 99.8 94.6 98.8 39.7 99.1 44.8 99.9 64.0
0.25 99.9 99.4 99.4 98.0 99.9 98.96 99.7 94.8 98.6 29.8 99.2 25.4 99.7 37.4
0.30 99.3 99.2 98.9 96.7 99.2 98.7 98.6 82.5 98.5 10.3 98.4 29.4 98.7 22.9
0.35 99.6 99.8 90.3 65.0 96.1 96.3 96.4 12.0 96.3 9.3 96.3 13.0 96.2 14.1
0.40 95.7 99.1 85.2 69.9 90.8 56.7 98.2 11.6 92.5 12.1 92.3 11.4 92.3 12.2
0.45 87.0 60.0 66.0 78.6 87.2 26.2 87.9 16.6 88.0 14.8 88.0 13.1 87.9 16.2
0.50 88.2 27.5 85.3 22.6 87.9 17.6 88.5 15.8 88.3 14.8 88.3 16.9 88.0 17.2
The first row indicates the dimension (number of columns and number of rows) of each module in the simulated dataset. The signal strength gradient within each module from
the strongest to weakest signal-to-noise ratio is provided in the second row. For example M1 has 25 pairwise tests (columns) and 250 gene sets (rows) and a signal-to-noise is
0.9 in the first few rows which decreases to 0.4 as the number of gene sets reaches 250. The remainder of the table shows the impact of increasing background noise (between 0
and 50%) on the mean specificity and sensitivity of 100 analyses (alpha¼0.3, selection pressure¼1.2, population size¼100, mutation rate¼0.08, success ratio¼0.6). Results
in which either sensitivity or specificity drop below 50% are highlighted with a grey background.
D.Gusenleitner et al.
2486module, relative to other gene sets in that module. This ranking allows
comparison of the relative importance of biological processes represented
by those gene sets.
2.2.2 Genetic algorithm Due to the high dimensionality of the as-
sociation matrix, it is not feasible to search the solution space of all
possible modules exhaustively; hence we use a genetic algorithm.
Genetic algorithms (GAs) are a class of heuristic search algorithms and
a particular form of optimization methods based on evolutionary con-
cepts. They use natural selection, recombination and sexual reproduction
in order to find heuristic solutions for optimization problems. In the GA
implemented in iBBiG, a module (individual) is represented by a binary
vector with length equal to the number of phenotypes, where 1 indicates
membership of a phenotype within a module. A population of such in-
dividuals is initialized by randomly selecting two phenotypes. The fitness
of each individual is evaluated using the entropy-based gene set score.
High-fitness individuals are chosen as parents to create the next gener-
ation of solutions, using a linear ranking selection operator (Chakraborty
and Chakraborty, 1997). A single-point crossover operator is used for
recombination and a bit flip operator for the mutation operator. An
offspring selection operator is used to introduce self adaptive selection
pressure (Affenzeller and Wagner, 2005). The algorithm produces gener-
ations of solutions, until the highest fitness score in the population stag-
nates for a specified number of generations.
2.2.3 Iterative module extraction The bi-clustering approach
described so far is able to find one module at a time. In order to find
all possible clusters, an iterative approach similar to that described by
Huttenhower et al. (2009) was applied. After finding a module K,t h e
weights of associations (Wik) between gene set i and phenotypes k in
module K are subtracted from the weighting matrix W and the
bi-clustering is applied again,
Wik ¼ Wikð1  ð 1   HiÞ
 Þ:
Few gene sets have associations with all k phenotypes (Hi¼0). Only the
portion of the signal used to calculate the fitness score is removed, as a
result a residual association signal Hi40 remains in the weight matrix.
Residual information not used in modules up to the current iteration is
available for subsequent iterations, ensuring iBBiG can find true over-
lapping clusters.
2.2.4 Optimization of iBBiG input parameters The optimal
range for each parameter of the GA was tested in 100 runs on simulated
data (Supplementary Tables S3–S7). The only parameter that had an
impact on the performance was the   parameter that regulates the weight-
ing between the homogeneity and module size (number of phenotypes)
(Supplementary Fig. S3). Experiments in which the   parameter was
varied 0.15 50.9) (Supplementary Table S2) show that the clustering
on the simulated datasets performs optimally (specificity 99.7% and sen-
sitivity 90.5%) with a value of  ¼0.3. Most other parameters had little
effect. Higher population size P, which is required to establish the neces-
sary amount of genetic diversity of solutions, shows only marginal dif-
ferences in sensitivity and specificity (Supplementary Table S3). The same
is true for the mutation rate MR (Supplementary Table S4), the selection
pressure for parent selection SP (Supplementary Table S5) and the suc-
cess ratio SR that determines how many children have to outperform at
least one of their parents (Supplementary Table S6). The optimal default
settings were determined to be an   of 0.3, a population size of 100
individuals, a mutation rate of 0.08, a success ratio of 0.6, a selection
pressure of 1.2 and a stop criterion of 50 iterations of stagnation.
2.2.5 Comparison to other clustering methods K-means cluster-
ing was performed using the ‘stats’ library in R with the parameter K¼7.
Hierarchical clustering was applied to an asymmetrical binary distance
matrix using Ward’s minimum variance method in both dimensions.
Bi-clustering methods:   clustering (Cheng and Church, 2000),
xMOTIF (Murali and Kasif, 2003), Bimax (Prelic, 2005), Plaid (Turner
et al., 2005) and SPEC (Kluger, 2003) were applied using default param-
eters using the R packages ‘biclust’ and ‘stats’, respectively. Over 130 runs
of Bimax were performed to optimize module size parameters minr (2–26)
and minc (2–20) that define module row and column size. FABIA
(Hochreiter et al., 2010) was applied using the R library ‘fabia’ to find
eight clusters (p¼8) in 1000 cycles (cyc¼1000) with different spareness
loading ( ¼0.1, 0.2 or 0.3). COALESCE (Huttenhower et al.,2 0 0 9 )
available in the Sleipnir package was performed using default parameters
for both initial cluster discovery and post-processing (COALESCE -j).
Each method detected different clusters, and results show the predicted
clusters with maximum pairwise Jaccard similarity index (JI) to each of
the ‘true’ modules M1–M7. In Supplementary Tables S10–16, JI was
calculated over phenotype membership, ignoring the ranking of the
gene sets. To assess iBBiG’s ability to assign gene sets to clusters
(Supplementary Tables S17), gene set scores for each predicted module
were subjected to Gaussian mixture modeling using the R function
‘mclust’ to discriminate gene sets with high scores from the background
null distribution.
2.2.6 Implementation Documentation and code are available in
the Bioconductor R package iBBiG. The core functions of the genetic
algorithm were implemented in C to speed computation.
3R E S U L T S
3.1 Robustness of iBBiG in the presence of increasing
noise
iBBiG maintained high performance predicting the strongest sig-
nals (M14M24M3) in the presence of up to 45% noise when
background noise was increased in 5% increments up to 50%
(Table 1). The weaker signal modules (M4–M7) show a high
level of specificity but a decline in sensitivity starting at 20%
noise. Increasing the   parameter (from the default of 0.3 to
0.5) increased sensitivity with a trade-off of decreased specificity.
The algorithm detected M4 to M7 at 25% noise, with an   of 0.5
(Supplementary Table S7). In addition, we evaluated the stability
of gene set scores over 100 runs (Supplemental Fig. S4). Within
each module, gene sets are ranked by a score that indicates the
number of phenotypes in which a gene set is differentially regu-
lated. We observed that gene sets with high scores showed low
variation among runs (Supplemental Fig. S4).
3.2 Performance of global and bi-clustering methods on
simulated meta-GSA data
Global clustering methods (hierarchical clustering, k-means) had
difficultly detecting overlapping modules in the simulated dataset
as shown in Figure 2A and Supplementary Figures 6A and 7,
respectively. Although hierarchical clustering discovers M3 with
high specificity and sensitivity, it was unable to detect overlap-
ping clusters; it either identified the large clusters (M1 and M2)
or the smaller clusters depending on the height of the dendro-
gram cut. Supplementary Figure 6B and C shows the maximum
JI between predicted and true clusters when dendrogram was cut
to give 3–15 clusters. When hierarchical clustering was per-
formed to produce the optimal number of clusters (K¼8) with
the highest average JI (Figures 6B and C), it was still unable to
discriminate M2 and its overlapping clusters M5 and M6 which
Bi-clustering of binary data
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S10).
Most genomics bi-clustering methods are not optimized for
binary data as they have been developed for gene expression
data with continuous values. Only FABIA, COALESCE and
Bimax discovered bi-clusters in the binary simulated data
matrix, the others tested ( -clustering, Plaid, SPEC, xMOTIF)
either did not accept a binary matrix as input or failed to find
clusters. FABIA performed only moderately well when applied
to the artificial dataset (Fig. 8). It tended to discover clusters with
large numbers of phenotypes which contained many false posi-
tives (Supplementary Fig. 8), for example the first cluster con-
tained almost all phenotypes (358/400) (Supplementary Table
S12). Increasing the alpha parameters from default (  ¼0.1) to
0.2 or 0.3 (Supplemental Tables   ¼0.2:13,   ¼0.3: 14) did im-
prove its ability to detect smaller clusters but still produced clus-
ters with high numbers of phenotypes and few gene sets. The
mean module specificity and precision of FABIA were 0.71, 0.71,
0.74 and 0.39, 0.38, 0.35 for alpha 0.1, 0.2, 0.3, respectively.
COALESCE outperforms most bi-clustering algorithms when
applied to gene expression data (Huttenhower et al., 2009), how-
ever only detected five of the seven clusters when applied to the
simulated data (Fig. 2B, Supplementary Table S11). It was
unable to discover the ‘tall’ module M1, which has few pheno-
types with a large number of gene sets and the smallest module
M6 which has overlaps in both M1 and M2.
Binary inclusion-maximal bi-clustering (Bimax) is arguably
one of the most popular binary bi-clustering algorithms, but it
is not optimized to tolerate noise in the signal (Prelic, 2005) and
produced small clusters with high specificity and poor sensitivity
in our simulated dataset (Supplementary Table S16). Bimax re-
quires that the number and size of clusters be specified as input
parameters. The simulated data contained modules of different
sizes, therefore we tested a large range of minimum row
(2 minr 26) and column size (2 minc 20), but the
maximum JI to M1-M7 ranged from 0.14 (M2) to 0.68 (M1)
(Supplementary Table S15), the best single combination was
minr¼22, minc¼4 (Supplementary Table S17) but this pro-
duced clusters of only four to six phenotypes which lacked sen-
sitivity 0.02 (M2)-0.24 (M1). No single combination of minr and
minc parameters could detect all seven modules due to their di-
verse sizes (Supplementalry Table S16).
3.3 Performance of iBBiG on simulated meta-GSA
dataset
Next, we applied iBBiG to the simulated data (Fig. 3). iBBiG
does not require the number of modules to be specified
and instead extracts an excess number (for example,
nModules¼20); the true number clusters are easily estimated
from the cluster weighted score that reflects the size and fitness
scores of each module. The modules are ranked in order of
decreasing score (Fig. 3A). Only 7/20 modules had a fitness
scores above background (Fig. 3A and C). The size of modules
dramatically decreases after Module 7; only low scoring groups
containing two or three phenotypes are found and these do not
have positive weighted scorces. Because we do not remove the
entire signal on each iteration, modules (which may be artifact)
will arise from remaining signal residue from stronger modules.
For example, phenotypes in M8 are a subset of those in M2.
Overlaps in phenotypes and gene sets of M3-M6 are detected
correctly.
To estimate the performance of iBBiG, it was applied to 100
randomly initialized artificial datasets (with k¼8) where it ac-
curately assigned phenotypes to modules 98% of the time, with a
specificity of 99%, precision of 96% and a sensitivity of 91%.
These statistics are based on correct identification of phenotypes
only and ignore gene set clustering (Supplementary Table S8).
We found iBBiG detected gene sets membership with high spe-
cificity (99%) and precision (92%) but lacked some sensitivity
(56%) following discretization of gene set scores (Supplementary
Fig. 2. Neither (A) hierarchical clustering or (B) COALESCE could detect all seven modules (M1–M7) in cluster analysis of the simulated dataset. True
modules are shown in dark gray, and detected modules are colored M1–M7 as indicated. (A) Rows and columns are ordered by hierarchical cluster
analysis (Wards minimum variance). Plots of the JI, which measured similarity between the true and predicted clusters when the dendrogram was cut to
give 3 K 15, are provided in the Supplement and show that K¼8 was optimal, but produced clusters that detected smaller overlapping clusters at the
cost of the large clusters (M1 and M2). The larger modules could only be detected when the dendrogram was cut to produce fewer clusters. (B) Rows and
columns have the same order as Figure 1. COALESCE detected five of the seven modules and had difficulty detecting M1 and M6. Bar plots show the
predicted module size (number of phenotypes and gene sets)
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2488Table S8). We do not expect to observe 100% sensitive detection
of gene sets in modules M1, M2, M4 or M5 as these contain gene
sets with less than 50% signal (Table 1). The best performing run
of 100 detected almost all module phenotypes (specificity 100%
and sensitivity 98%) and more gene sets (specificity 99.7% and
sensitivity 72.5%) (Supplementary Table S9). The performance
of iBBiG gene set prediction was also assessed by calculating of
the variance of the scores within 100 runs (Supplementary Fig. 4)
and calculating the ROC curves for each module on one run
(Supplementary Fig. 5). The average runtime for the 400x400
matrix was 69.3 s on an Intel Core 2 Duo (3 GHz) running
Windows XP.
3.4 iBBiG discovers 13 modules of breast cancer (GSVA
analysis of three datasets)
We can uncover gene sets associated with unknown clinical cov-
ariates using single sample GSA (e.g. GSVA). iBBiG is optimized
to find overlapping bi-clusters in these complex data which can
reveal new biological pathways associated with disease. When
applied to 1008 gene expression profiles of primary breast
tumors from three studies (Kao et al., 2011; Minn et al., 2007:
van’t Veer et al., 2002) that had been obtained on different
technological platforms each containing different numbers of
features, iBBiG detected 13 modules with positive weighted
scores (Figure 4). The first four modules (M1–M4) were strongly
associated with breast cancer molecular subtypes Luminal A,
Basal-like, Luminal A or B and Basal like or HER2, respectively
(Fig. 4, Supplementary Table S18). Both M1 and M2 were en-
riched in cell proliferation genes and were highly predictive of
tumor recurrence in all cancer subtypes and within Luminal A
and Luminal B, respectively (Supplementary Table S18,
Supplementary Figs. S11–18). Most other modules were subsets
of samples in these modules but had different gene sets. For
example, M9 contains different proliferative gene sets, and over-
lapped with M1 and M3. Although M11 overlapped with M4, it
discovered a subset of poor prognosis basal-like patients and it
was prognostic of metastases recurrence within the basal-like
breast cancer (P50.01). M10 (Supplementary Fig. 19) was par-
ticularly interesting as it appears to predict patient prognosis
within Luminal A and ERRB2 subtypes (DMFS, P50.001,
Supplementary Figs. S20–22). There were 177 gene sets in M12
(Supplementary Fig. 19 and Table S19), which were associated
with a stromal response to hypoxia and induction of angiogentic
genes including TGFB1. The five top genes all contained tran-
scription factor binding sites for V$ATF4_Q2 (GATHER,
P50.0005) and 3/5 contained sites for V$OCT1_05
(GATHER, P50.0003) and are enriched in Gene Ontology
terms GO:0045906 (negative regulation of vasoconstriction)
and GO:0006701 (progesterone biosynthetic process), suggesting
new avenues for research in these breast cancer subtypes.
3.5 iBBiG identifies eight modules associated with known
clinical covariates in breast cancer
iBBiG was applied to extract 50 modules in a meta-GSA of
known clinical covariates (GSEAlm) associated with 3875 gene
expression profiles of breast tumors from 21 different studies
obtained on diverse platforms that were available in GCOD
(Liu et al., 2011). It extracted eight modules (Fig. S4) which
had between 9 and 43 pairwise tests (total n¼448)
(Supplementary Table 20). The largest, highest scoring module,
B1, was among five modules (B1, B2, B4, B7 and B8) enriched in
the phenotype (pairwise comparison) high versus low grade.
Although all associated with tumor grade, gene sets in each
module represented diverse biological actions; proliferation (B1
and B8), wound healing and cell–cell communication (B2), in-
flammatory processes and the tumor microenvironment (B4) and
extracellular matrix (B7). Module 8 (B8) is a residue of the pro-
liferation signal of B1 and all gene sets contained in B8 are also
present in B1. Modules B3, B5 and B6 were associated with
hormone receptor-positive luminal breast cancer. The Module
B3 was associated with low grade cancer or normal tissue cov-
ariate pair tests and points towards the requirement of a high
grade-cancer to dedifferentiate itself. The modules B5 and B6
were associated with protein processing (Supplementary Table
S20 and Fig. S4).
We investigated two modules (B1 and B4) associated with p53
mutated, hormone receptor (ER-, PR-) negative, basal-like
breast cancer—a poor prognosis subtype with few targeted thera-
pies. While the importance of proliferation (B1) is well described,
module B4 was of considerable biological interest
(Supplementary Fig. 25) as it was characterized by immune
and tumor microenvironment genes sets, including cytotoxic
T-cell pathway, and the cytokine pathways IL-12 and IL-17.
These genesets (B4) were associated with high-grade basal-like
and luminal B tumors but were not associated with metastases
(Supplementary Fig. S25). Survival analysis of a number of genes
in this module in six publicly available datasets confirmed they
were predictive of better outcome in Basal-like and ERBB2þ
breast cancer (Supplementary Fig. S26).
4D I S C U S S I O N
The iBBiG bi-clustering algorithm is optimized for module dis-





Fig. 3. iBBiG bi-cluster analysis of the simulated dataset detects all mod-
ules (M1–M7) including those with overlaps (M3–M6). Plots show the
(A) fitness score (S) (B) size (k)a n d(C) weighted score of the first eight
modules. The weighted score is the log(k/m*S) where m is the total
number of phenotypes. Modules M1–M7 are highlighted in (D) an
image of the matrix in which rows and columns have the same order as
Figure 1. The eighth module (M8) contains the residues of other modules
which is reflected in a low weighted score
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2489meta-GSA of multiple genomics datasets, to discover modules:
groups of phenotypes whose differential gene expression profiles
are enriched in the same gene sets. Data integration is made
tractable by transformation of continuous ‘noisy’ gene expres-
sion data (with different probes/genes in each study) into profiles
of differentially enriched gene sets (which are common to all
studies). We examined two GSA approaches, GSEAlm which
tests for enrichment of gene sets in genes that are differentially
regulated between conditions and GSVA which is single sample
GSA. The former can be applied to identifying gene sets or path-
ways associated with known clinical covariates, the latter is a
pure discovery approach that ignores prior sample knowledge.
We designed iBBiG to have high specificity and thereby min-
imize the false-positive rate when discovering new classes, but the
iterative approach employed in iBBiG ensures it is sufficiently
sensitive to discover weak signals, even if they are potentially
masked by stronger ones. When applied to simulated data it
outperforms widely used global clustering approaches (K-
means, hierarchical cluster analysis) and newer bi-clustering
approaches (Bimax, FABIA and COALESCE) and is able to
find overlapping gene set modules of varying sizes. iBBiG was
able to identify all clusters in a simulated meta-GSA dataset with
high levels of specificity and sensitivity. An advantage of iBBiG
relative to other methods is that it does not require a priori
knowledge of the true number of clusters. Following the appli-
cation of iBBiG, the number of true clusters can be estimated
from the weighed scores of the extracted modules. In some cases,
we observed that a module may represent the residue or remain-
ing signal of a stronger, previously extracted module. This resi-
due remains because iBBiG only removes information from the
data matrix that is actually used for the entropy-based score in a
module. However, we do not consider these residual modules to
be a shortcoming of the method as their existence facilitates dis-
covery of the true overlap between modules and, further, these
modules can be easily detected by looking at the overlap of
phenotypes and gene sets.
Although iBBiG includes several parameters, we have shown
that most impact only computation time and do not effect cluster
discovery. The only parameter that had an impact on cluster
discovery was  , which regulates the weighting between cluster
homogeneity and the number of phenotypes. This parameter is
useful in fine-adjustment of the sensitivity–specificity ratio.
One major advantage of iBBiG is its robustness in the presence
of noise and its tolerance of missing data. It can tolerate high
levels of noise as the entropy derived fitness score add members
to a bi-cluster once the number of associations exceeds 50%. We
demonstrate that iBBiG performs well even in the presence of
false-positive associations and noise in both signal (20%) and
background (40%). Second, iBBiG does not require a gene set
to be associated with all phenotypes in a bi-cluster which is a
attractive feature in complex biological data were biological pro-
cesses maybe redundant or regulated by multiple factors concur-
rently. Many other bi-clustering algorithms, including Bimax
and the recently described BiBiT (Rodriguez-Baena et al.,
2011), discover only homogenous bi-clusters and have low toler-
ance to noise and missing data. Bimax identified a large number
of mini-bi-clusters and was unable to identify large clusters in our
simulated dataset. In practice, application of Bimax to genomics
data requires post-processing of bi-cluster results in order to
either join or visualize overlapping bi-clusters (Santamaria
et al., 2008).
We applied iBBiG to discovery of new modules among 1008
primary breast tumors and discovered 13 modules in an
iBBiG-GSVA analysis. Each module contained samples from
multiple studies demonstrating successful data integration.
While the largest highest confidence modules (M1–M4) dis-
covered breast cancer molecular subtypes known to be important
in breast cancer, the smaller modules represented sub-sets of
these subtypes, supporting recent evidence that there are sub-
types within each of the principal breast cancer molecular sub-
types (Curtis et al., 2012). The module M10 was characterized
by gene sets associated with angiogenesis in response to hypoxia
(or HIF1A degregulation) and was a strong predictor of recur-
rence in Luminal and ERRB2 amplied breast cancer. We un-
covered different modules (n¼8) associated with pairwise tests
of breast cancer clinical covariates in a meta-GSA of 21 breast
cancer gene expression datasets. Five of the eight modules
including the first and largest module was strongly associated
with tumor grade. Most high grade tumors were characterized
by increased cell cycle (B1/B8) and those with fewer metastases
had significant regulation of immune response genes (B4). In a
meta-analysis of two datasets, Shi et al., (2010) also reported an
Fig. 4. Meta-GSA using iBBiG bi-clustering of GSVA associations be-
tween 2459 gene sets which are up- or down-regulated (n¼5098) in gene
expression profiles of 1008 primary breast cancer tissue samples, obtained
using different array platforms in three independent studies (KAO, NKI
and VDX). Phenotypes and the gene sets are ordered according to
module membership in an image that highlights modules (n¼13) that
had a weighted score greater than zero. Color bars above the plots indi-
cate the study, molecular subtype and distant metastases free surival
events of patients. These are brown (KAO)/yellow (VDX)/green (NKI)/
red (basal-like)/pink (HER2 amplified)/Luminal B (navy)/Luminal A
(cyan)/no distant metastases (gray) and distant metastases (yellow), re-
spectively. The largest and first four modules were strongly associated
with molecular subtype across studies being enriched in Luminal A (M1),
Basal-like (M2), Luminal A or B (M3) and Basal-like or HER2 (M4)
respectively. Further details are given in the text and in Supplementary
Table S18. Plots below the image show the fitness size, score and weighted
score of each modules
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2490up-regulation of proliferation genes and down-regulation of cell
adhesion genes in high-grade breast tumors. Although they had
insufficient numbers of patients to establish statistical signifi-
cance, they observed that high levels of immune genes were an
indicator of good prognosis in high-grade breast cancer patients.
Our analysis also suggests B4 immune response is associated with
better outcome. When we examined which genes that most fre-
quently appeared in module B4 GeneSigDB gene signatures, we
found several chemokines including CCL5 (RANTES), a key
regulators of T-cell immune response highly expressed in breast
cancer and reported to be associated with metastases and pro-
gression (Soria and Ben-Baruch, 2008; Zhang et al., 2009).
However, our analysis does not fit this prevailing hypothesis
and suggests CCL5 is associated with good prognosis in
high-grade breast cancer patients.
In this study, we have used iBBiG to discover clusters in matri-
ces of discretized P-values from GSA of gene expression data;
however, the method can also be easily applied to GSA of other
different data types including SNP data (Cantor et al., 2010;
Raychaudhuri et al., 2009). iBBiG can be applied to non-geneset
data. For example, to demonstrate the application of iBBiG to
an extremely sparse matrix (50.3%40) in which small clusters
are expected, iBBiG was applied to discretized data from the
NHGRI genome-wide association study (GWAS) catalog
(Hindorff et al., 2009). As the weighted scores were low for mod-
ules identified, we averaged results over 100 runs of iBBiG and
chose 10 robust modules. Only genes and traits that occured in at
least 65/100 runs were included (Supplementary Fig. S27). These
modules are provided in Supplementary Table S22. It discovered
a possible link between triglyercides, HDL cholesterol and
waist circumference with genes GCKR, LPL, BUD13 and
ZNF259. Although LPL, BUD13 and ZNF259 has been impli-
cated previously, this module suggested a new link with an ex-
panding waistline and GCKR. While GSA requires input gene
sets, it is not restricted to databases of curated gene sets and can
use gene sets deduced through text mining from the published
literature (Jelier et al., 2011; Krallinger et al., 2010;
Raychaudhuri et al., 2009). We anticipate iBBiG will be useful
in integrated data analysis of multiple data types. iBBiG can be
performed on any binary matrix and could be applied to binary
protein–protein interaction or RNAi data; we would like to
extend it to other data types, including categorical data. An at-
tractive feature of iBBiG compared to others methods such as
the recently described logistic regression meta-GSA approach
(Montaner and Dopazo, 2010) is its ability to perform integrative
analysis using dozens of datasets.
In summary, iBBiG provides a simple, robust, rapid and scal-
able method for meta-GSA. When applied to simulated data it
outperforms commonly used clustering and bi-clustering
approaches and iteratively discovers gene set modules made up
of both strong and weaker signals. Meta-GSA using iBBiG con-
stitutes a new approach for discovery of pathway and gene set
behavior across multiple studies and provides a higher-level
understanding of gene and cellular function.
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